Investopedia

Investopedia
Share

Investopedia

 •  April 13

China has long been known as an unimaginative producer of copycat pills and cheap ingredients for drugs. But that's changing dramatically as Chinese biotechnology start-ups partner with the world’s biggest drug companies to develop new medicines to treat everything from cancer to hepatitis, according to the Wall Street Journal. Since Johnson &...

Investopedia

 •  March 24

) announced that the Drug Enforcement Agency (DEA) has issued an interim final rule that would classify its long-approved oral drug, Syndros (dronabinol), as a Schedule II drug under the Controlled Substances Act. Schedule II substances have a high potential for abuse, dependence and addiction. Syndros was approved in July 2016 by the U.S. Food And...

Investopedia

 •  March 2

Aurinia Pharmaceuticals Inc. (AUPH) said its mid-stage lupus drug, voclosporin, shows no new safety concerns. The update has allayed ongoing concerns about the drug’s safety, after the Canada-based biopharmaceutical company reported 13 trial deaths in August 2016. Among those, 12 deaths occurred in voclosporin-treated patients after 24 weeks of...

Investopedia

 •  March 2

Many American consumers of prescription drugs often dread the month of January, when pharmaceutical companies formally raise their list prices. But this year may be different. Price increases slowed markedly on a wider number of drugs. The driving force for this change is stiff criticism from President Donald Trump and others about price gouging,...

Investopedia

 •  February 27

In their rush to development new treatments for a largely unknown fatty liver disease called Nash, large drug companies such as Allergan (AGN), Shire (SHPG), Gilead (GILD) and Novo Nordisk (NVO) are spending billions of dollars, reported the Financial Times. At its peak, it's expected to generate $35 billion in annual revenue, making it a huge...

Investopedia

 •  February 27

Idera Pharmaceuticals Inc. (IDRA) reported supplementary data from the dose-escalation stage of its Phase 1/2 clinical trial of its metastatic melanoma combination therapy involving its intra-tumoral drug candidate IMO-2125. (For more, see Top Cancer Drugs with High Future Sales Potential.) The company said it successfully achieved all the desired...

Investopedia

 •  February 24

Aveo Pharmaceuticals Inc. (AVEO) said its cancer drug, tivozanib, passed safety review by the study’s Safety Monitoring Committee. The Phase 3 trial, called TIVO-3, compared Aveo’s tivozanib to Bayer/Onyx's rival drug Nexavar (sorafenib) for treating refractory advanced renal cell carcinoma. The Safety Monitoring Committee concluded there were no...

Investopedia

 •  February 21

Amphastar Pharmaceuticals Inc. (AMPH) said the FDA rejected its Naloxone Hydrochloride 2mg/0.5mL nasal spray, an intranasal version of the emergency opioid-overdose drug. Amphastar stock plunged 21% on the update. AMPH traded at $14.57 per share, down $3.83, on Tuesday afternoon on unusually heavy volume, suggesting a mass sell-off. The complete...